JPMorgan: 2 biopharma stock picks

Prediction   #biopharma #xene #stockpick #bgne  

#stockpick #biopharma pc[Covering the stock for JPMorgan, analyst Xiling Chen believes #BGNE presents a compelling risk reward. Kumar rates the stock an Overweight (i.e. Buy) along with a $296 price target that implies a 50% one-year upside.]ce #checkafter1year Predicted By Xiling Chen, Analyst at JPMorgan.

1 Need login or sign up to read prediction basis.

pc[Romero rates shares in #XENE as Overweight (i.e. Buy), and her $55 price target implies a 46% upside by the end of next year. ]ce #checkafter1year Predicted By Tessa Romero, Analyst at JPMorgan.

2 Need login or sign up to read prediction basis.